Vera Therapeutics is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Vera Therapeutics is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. Its lead product candidate is atacicept, a fusion protein that blocks B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), targeting autoimmune diseases such as IgA nephropathy and lupus nephritis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.